Clinical Trials on BRAFV600E Melanoma Patients in Australia
Total 351 results
-
Southwest Oncology GroupNational Cancer Institute (NCI); Eastern Cooperative Oncology Group; Children... and other collaboratorsCompletedMelanoma (Skin)United States, Australia
-
Melanoma and Skin Cancer Trials LimitedMelanoma Institute AustraliaCompletedLentigo MalignaAustralia, Brazil, New Zealand
-
Canadian Cancer Trials GroupMelanoma and Skin Cancer Trials LimitedRecruitingUnresectable/Metastatic MelanomaCanada, Australia
-
Ascentage Pharma Group Inc.Merck Sharp & Dohme LLCRecruitingMelanoma | P53 Mutation | Uveal Melanoma | Cutaneous Melanoma | Mucosal Melanoma | Malignant Peripheral Nerve Sheath Tumors | MPNST | Unresectable or Metastatic Melanoma or Advanced Solid Tumors | MDM2 Gene MutationUnited States, Australia
-
Bristol-Myers SquibbCompletedMelanomaCanada, Australia, Germany, Italy, Poland, France, Denmark, Argentina, Chile, Spain, Norway, Israel, Sweden, Mexico, Greece, Finland
-
AmgenMerck Sharp & Dohme LLCTerminatedMelanomaUnited States, Finland, France, Germany, Italy, Canada, Czechia, Poland, Switzerland, Korea, Republic of, Russian Federation, United Kingdom, Australia, Netherlands, Spain, Austria, Belgium, Hungary, Portugal, Greece, South Africa
-
Kepler University HospitalRISC Software GmbH; innovethic eU; FiveSquare GmbHActive, not recruiting
-
GlaxoSmithKlineCompletedCancerAustralia, Spain, United States, Germany, Poland, Italy, Canada, Ireland, Hungary, Russian Federation, Netherlands, France
-
Immunocore LtdRecruitingAdvanced MelanomaUnited States, Australia, Spain, Italy, Germany, Belgium, United Kingdom, Poland, France, Austria, Switzerland
-
Bristol-Myers SquibbTerminatedStudy to Compare the Effect of Ipilimumab Retreatment With That of Chemotherapy in Advanced MelanomaMelanomaFrance, United States, Italy, Germany, Austria
-
Bristol-Myers SquibbCompletedMelanomaBelgium, Brazil, United States, Canada, Spain, Greece, France, United Kingdom, Australia, Italy, Austria, Switzerland, Germany, Israel, Russian Federation, Romania, Czechia, Poland, New Zealand
-
Fondazione Melanoma OnlusClinical Research Technology S.r.l.CompletedMetastatic MelanomaItaly, Germany, Spain, Greece, Austria, France, Poland, Sweden, Switzerland, United Kingdom
-
Bristol-Myers SquibbActive, not recruitingMelanomaItaly, United States, Germany, Argentina, Australia, Austria, Belgium, Brazil, Canada, Chile, Colombia, Denmark, Finland, France, Greece, Israel, Mexico, New Zealand, Norway, Poland, Romania, Russian Federation, Spain, Sweden, United Kingdom
-
Hoffmann-La RocheCompletedMelanomaUnited States, Italy, Australia, France, Spain, Netherlands
-
Merck Sharp & Dohme LLCActive, not recruitingMelanomaUnited States, Australia, France, Israel, Italy, Switzerland
-
GlaxoSmithKlineCompletedMelanomaFrance, Italy, Germany, Netherlands, Switzerland, United Kingdom, Austria, Australia
-
Merck Sharp & Dohme LLCActive, not recruitingMelanomaUnited States, Australia, France, Israel, Italy, Switzerland
-
Bristol-Myers SquibbCompletedMelanomaItaly, Netherlands, Russian Federation, Czechia, Hungary, Ireland, Norway, Spain, Switzerland, Austria, Germany, Denmark, France, Belgium, United Kingdom, United States
-
Melanoma and Skin Cancer Trials LimitedMonash University; University of Sydney; The University of QueenslandActive, not recruitingMelanoma | Skin Cancer | Anxiety and FearAustralia
-
BayerAmgenCompletedMelanomaUnited States, Canada, Germany, France, United Kingdom, Australia, Netherlands
-
Bristol-Myers SquibbCompletedMelanomaUnited States, Australia, Belgium, Italy, Poland, Spain, United Kingdom
-
Novartis PharmaceuticalsCompletedMelanomaCanada, Spain, United Kingdom, Netherlands, United States, Argentina, Australia, France, Germany, Greece, Italy, Russian Federation, Sweden, Ukraine
-
SanofiActive, not recruitingMalignant Melanoma | Squamous Cell Carcinoma of SkinGermany, Spain, France, Chile, United States, Australia, Italy
-
Eli Lilly and CompanyTerminatedMelanomaUnited States, Italy, Australia, Spain, France, Netherlands, United Kingdom, Austria, Poland, Germany, Belgium, Taiwan, Canada, Finland, Israel, Korea, Republic of, Norway, Sweden
-
European Organisation for Research and Treatment...NCIC Clinical Trials GroupUnknownUlcerated MelanomasFrance, Denmark, Italy, Belgium, Spain, United Kingdom, Netherlands, Austria, Germany, Poland, Switzerland, Portugal
-
Pierre Fabre MedicamentEuropean Organisation for Research and Treatment of Cancer - EORTCActive, not recruitingMelanomaSpain, Canada, Hungary, Italy, Belgium, Netherlands, Australia, Czechia, Greece, Brazil, Portugal, Serbia, Sweden, Norway, Germany, Argentina, Romania, Poland, United Kingdom, Austria, Switzerland, France, South Africa
-
Medical University of GrazCompletedNFAT Regulated Gene Expression in Tacrolimus Treated PatientsAustria
-
Genentech, Inc.Active, not recruitingMelanomaUnited States, Germany, Australia, Korea, Republic of, Canada, Norway
-
Novartis PharmaceuticalsCompletedMelanomaUnited States, Belgium, Canada, Spain, United Kingdom, Netherlands, Argentina, Australia, Austria, Brazil, Czechia, Denmark, France, Germany, Greece, Israel, Italy, Japan, New Zealand, Norway, Poland, Russian Federation, Sweden, Switz... and more
-
EBG MedAustron GmbHRecruiting
-
Medical University of GrazUnknownLentigo MalignaAustria
-
Agenus Inc.CompletedMalignant MelanomaUnited States, Australia, Poland, Ukraine, United Kingdom, Russian Federation, Hungary, Italy, Sweden
-
ModernaTX, Inc.Merck Sharp & Dohme LLCRecruiting
-
Monash UniversityNational Health and Medical Research Council, AustraliaRecruitingMelanoma | AtherosclerosisAustralia
-
Immunocore LtdActive, not recruitingUveal MelanomaUnited States, Canada, United Kingdom, Spain, France, Germany, Poland, Australia, Belgium, Italy, Netherlands, Russian Federation, Switzerland, Ukraine
-
Medical University of ViennaCompletedPerioperative | Brain Natriuretic Peptide | Supplemental Oxygen | Cardiac Risk PatientsAustria
-
AstraZenecaCompletedMelanomaUnited States, Italy, Spain, Sweden, Belgium, Canada, Poland, Switzerland, France, Russian Federation, United Kingdom, Australia, Argentina, Germany, Netherlands, Israel, South Africa, Austria, Greece, Mexico, Slovakia
-
Medical University of GrazBoehringer MannheimCompletedLong-Term Oral Anticoagulated PatientsAustria, Germany
-
Novartis PharmaceuticalsCompletedMelanomaUnited States, United Kingdom, Austria, Belgium, Hungary, Canada, Netherlands, Argentina, Australia, Brazil, Czechia, Denmark, France, Germany, Israel, Italy, Norway, Poland, Russian Federation, Spain, Switzerland, Taiwan, Korea, Republic... and more
-
Medical University of ViennaCompletedPatient SatisfactionAustria
-
Hoffmann-La RocheRecruitingMelanomaBrazil, Czechia, Spain, Turkey, New Zealand, Canada, Australia, Poland, Slovakia, Greece
-
Bristol-Myers SquibbActive, not recruitingMelanomaUnited States, Italy, Argentina, Australia, Austria, Belgium, Brazil, Canada, Chile, China, Czechia, Denmark, Finland, France, Germany, Greece, Israel, Mexico, Norway, Romania, Spain, Sweden, Switzerland, United Kingdom
-
Bristol-Myers SquibbCompletedMelanomaBrazil, Chile, United States, Ireland, Italy, Spain, Argentina, Australia, Canada, France, Mexico, New Zealand, Poland, Romania
-
Melbourne HealthRecruitingVital Signs | Inpatients | Hospital-at-homeAustralia
-
Synta Pharmaceuticals Corp.TerminatedMelanomaUnited States, Spain, Canada, Australia, Germany, Puerto Rico, Romania, United Kingdom
-
Foundation for Cardiovascular Research, ZurichAbbott Medical DevicesUnknownHeart Septal Defects, Atrial | Embolism, ParadoxicalAustralia, Austria, Belgium, Switzerland
-
Melanoma Institute AustraliaBristol-Myers Squibb; Melanoma and Skin Cancer Trials LimitedActive, not recruitingMelanoma | Brain MetastasesAustralia
-
Neovii BiotechTerminatedEpithelial Cancer PatientsAustria, Denmark, Spain
-
Genta IncorporatedCompletedMelanomaUnited States, France, United Kingdom, Spain, Switzerland, Australia, Canada, Germany, Poland, Italy, Austria, Czech Republic
-
GlaxoSmithKlineCompletedMelanoma and Brain MetastasesAustralia, Germany, United States, Canada, Italy, France